AI helps doctors remember what patients want at end of life
NCT ID NCT07147023
First seen Oct 31, 2025 · Last updated Jun 20, 2026 · Updated 39 times
Summary
This study tests whether an AI tool can accurately summarize serious illness conversations between doctors and patients with advanced cancer. The AI-generated summaries are emailed to clinicians to help them keep track of patient goals and preferences. Researchers will check the summaries for accuracy and ask doctors and patients for their feedback.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Large Language Model (AI) generated summaries of serious illness conversations
What this could lead to
If successful, this could help doctors quickly understand a patient's care preferences, improving end-of-life communication and alignment with patient goals.
What could go wrong
This is a small pilot study with only 60 participants, testing accuracy and feasibility—not whether it improves outcomes. AI summaries may miss or misinterpret key details.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.